Therefore, associations between TIM-3 expression and improved DFS in CD8+ and FoxP3-expressing CD8+ TILs provide evidence for its immunomodulatory roles, which may be beneficial in limiting tumor progression. The gene discussed is CD8A; the disease is neoplasm.